Correlation Between Neuropace and Talis Biomedical
Can any of the company-specific risk be diversified away by investing in both Neuropace and Talis Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Talis Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Talis Biomedical Corp, you can compare the effects of market volatilities on Neuropace and Talis Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Talis Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Talis Biomedical.
Diversification Opportunities for Neuropace and Talis Biomedical
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Neuropace and Talis is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Talis Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talis Biomedical Corp and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Talis Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talis Biomedical Corp has no effect on the direction of Neuropace i.e., Neuropace and Talis Biomedical go up and down completely randomly.
Pair Corralation between Neuropace and Talis Biomedical
If you would invest 590.00 in Neuropace on August 24, 2024 and sell it today you would earn a total of 310.00 from holding Neuropace or generate 52.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Neuropace vs. Talis Biomedical Corp
Performance |
| Timeline |
| Neuropace |
| Talis Biomedical Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neuropace and Talis Biomedical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neuropace and Talis Biomedical
The main advantage of trading using opposite Neuropace and Talis Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Talis Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talis Biomedical will offset losses from the drop in Talis Biomedical's long position.| Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
| Talis Biomedical vs. Tivic Health Systems | Talis Biomedical vs. Bluejay Diagnostics | Talis Biomedical vs. Heart Test Laboratories | Talis Biomedical vs. Nuwellis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |